Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV003595674 | SCV001216817 | likely benign | FG syndrome | 2023-10-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003307863 | SCV004003935 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2023-05-17 | criteria provided, single submitter | clinical testing | The p.R1329G variant (also known as c.3985C>G), located in coding exon 28 of the MED12 gene, results from a C to G substitution at nucleotide position 3985. The arginine at codon 1329 is replaced by glycine, an amino acid with dissimilar properties. Based on data from gnomAD, the G allele has an overall frequency of 0.002% (4/198121) total alleles studied, with 1 hemizygote observed. The highest observed frequency was 0.003% (3/89384) of European (non-Finnish) alleles. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |